In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway

Yu Ling Lin, Nu Man Tsai, Cheng Hao Hsieh, Shu Yi Ho, Jung Chang, Hsin Yi Wu, Ming Hua Hsu, Chia-Ching Chang, Kuang-Wen Liao*, Tiffany L.B. Jackson, David E. Mold, Ru Chih C. Huang

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science